Changes and significance of serum TPS and ILG6 after TACE treatment of hepatocellular carcinoma

VernacularTitle:血清TPS、IL-6 在肝细胞肝癌经肝动脉化疗栓塞术治疗后的变化及意义
Author: Xuli MIN ¹ ; Hao XU ; Lin YANG ; Hanfeng YANG ; Yongjun REN
Author Information

1. 川北医学院附属医院放射科
Keywords: hepatocellular carcinoma; transcatheter arterial chemoembolization; tryptase; interleuk-6
From: Journal of Practical Radiology 2019;35(10):1603-1606
CountryChina
Language:Chinese
Abstract: Objective To explore the changes of serum tryptase(TPS)and interleuk-6 (IL-6)levels before and after TACE treatment in patients with hepatocellular carcinoma (HCC).Methods ELISA was used to detect the serum TPS and IL-6 levels in 5 1 patients with HCC 1 day before and 1 day,1 week and 1 month after TACE.30 healthy people were enrolled as a control group.Results Serum TPS and IL-6 levels in observation group before TACE were higher than those in control group (P＜0.05),and serum TPS level in the observation group was positively correlated with serum IL-6 level (P＜0.05)before TACE.Serum TPS and IL-6 levels in the response group one month after TACE were lower than those one day before TACE (P＜0.05),while compared with those one day before TACE ,the non-response group increased slightly and non significance was showed(P＞0.05).Conclusion Serum TPS and IL-6 levels are closely related to the response of HCC to TACE treatment,thus these may be used to evaluate the efficacy of TACE in treatment of HCC.